IGF1R and lung carcinoma: Guix et al. [29] also discovered that IGF-1 activated IGF1R in lung cancer cells, and showed that only cells, which depended on IGF1R and its downstream signaling pathways to promote cell growth, acquired the resistance ability against geftinib.